Weiliang Jiang

Prof. Dr. Weiliang Jiang


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2022 in Science Translational Medicine
Verified
Journal Article
Closed access
WJWeiliang Jiang
Weiliang Jiang
LJLinzi Jin
Linzi Jin
DJDapeng Ju
Dapeng Ju
ZLZhanjun Lu
Zhanjun Lu
CWChuanyang Wang
Chuanyang Wang
RWRong Wan
Rong Wan
Chronic pancreatitis (CP) is characterized by progressive fibrosis and exocrine dysregulation, which have long been considered irreversible. As a peripheral oscillator, the pancreas harbors autonomous and self-sustained timekeeping systems in both its endocrine and exocrine compartments, although the role of the latter remains poorly understood. By using different models of CP established in mice with dysfunctional pancreatic clocks, we found that the local clock played an important role in CP pathology, and genetic or external disruption of the pancreatic clock exacerbated fibrogenesis and exocrine insufficiency. Mechanistically, an impaired retinoic acid receptor–related orphan receptor A (Rora)/nuclear receptor subfamily 1, group D, member 1 (Nr1d1)/aryl hydrocarbon receptor nuclear translocator-like (Arntl or Bmal1) loop, called the circadian stabilizing loop, resulted in the deficiency of pancreatic Bmal1, which was responsible for controlling the fibrogenic properties of pancreatic stellate cells (PSCs) and for rewiring the function of acinar cells in a clock–TGF signaling–IL-11/IL-11RA axis–dependent manner. During PSC activation, the antagonistic interaction between Nr1d1 and Rora was unbalanced in response to the loss of cytoplasmic retinoid-containing lipid droplets. Patients with CP also exhibited reduced production of endogenous melatonin. Enhancing the clock through pharmacological restoration of the circadian stabilizing loop using a combination of melatonin and the Rora agonist SR1078 attenuated intrapancreatic pathological changes in mouse models of CP. Collectively, this study identified a protective role of the pancreatic clock against pancreatic fibrosis and exocrine dysfunction. Pancreatic clock–targeted therapy may represent a potential strategy to treat CP.

6 March 2023 in Esophagus
Verified
Journal Article
Open access
PDF file
SSShien Shen
Shien Shen
GYGe Yu
Ge Yu
XGXingya Guo
Xingya Guo
GZGuanzhao Zong
Guanzhao Zong
CWChuanyang Wang
Chuanyang Wang
RWRong Wan
Rong Wan
Background: To evaluate the long-term efficacy of transoral incisionless fundoplication (TIF) with Medigus Ultrasonic Surgical Endostapler (MUSE) for gastroesophageal reflux disease (GERD). Methods: A total of 16 patients with proton pump inhibitor-dependent gastroesophageal reflux disease had undergone TIF by MUSE in Shanghai General Hospital (Shanghai, China)from March 2017 to December 2018. Patients were followed up at 6 months, and the GERD-health-related quality of life (GERD-HRQL) questionnaire score, the GERD questionnaire (GERD-Q) score, high-resolution esophageal manometry (HREM) and 24 h esophageal pH parameters, the Hill grade of the gastroesophageal flap valve (GEFV) and daily Proton pump inhibitor (PPI) consumption before and after procedure were compared. Patients also were followed up at 3 years and 5 years using a structured questionnaire via phone which evaluated symptoms of reflux, dose of PPI medication and side effects. Results: Follow-up data were collected from 13 patients, ranging from 38 to 63 months, 53 months on average. 10/13 patients reported symptomatic improvement and daily PPI consumption was stopped or halved in 11/13. After procedure, the mean scores of GERD-HRQL and GERD-Q were significantly increased. The mean DeMeester score, the mean acid exposure time percentage and the mean number of acid reflux episodes were significantly lower. The mean rest pressure at lower esophageal sphincter (LES) had no significant difference. Conclusion: TIF by MUSE has significant efficacy in the treatment of PPI-dependent GERD, which can improve symptoms and life quality of patients, and reduce the acid exposure time for long-term. Chictr.org.cn. Trial Registration: ChiCTR2000034350.

31 January 2026 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
CZChengying Zhu
Chengying Zhu
ZLZeming Le
Zeming Le
ZLZhanjun Lu
Zhanjun Lu
ZGZihao Guo
Zihao Guo
GYGuo Yu
Guo Yu
WXWenqin Xiao
Wenqin Xiao
Gastroesophageal reflux disease (GERD) is a common chronic digestive disorder with a growing epidemiological footprint worldwide. However, the specific cha

26 November 2025 in Discover Oncology
Verified
Journal Article
Open access
PDF file
ZCZhiyuan Cheng
Zhiyuan Cheng
CYChuting Yu
Chuting Yu
BQBin Quan
Bin Quan
KZKena Zhou
Kena Zhou
CHChongxin He
Chongxin He
WJWeiliang Jiang
Weiliang Jiang
Background Circadian dysregulation has been shown to be associated with the progression of pancreatic cancer (PC). However, the circadian machinery comprises numerous circadian rhythm-related genes (CRRGs), whose roles in tumor biology remain unclear. Methods A metastasis-related rhythmic gene signature (MRRGS) was established based on differentially expressed genes (DEGs) identified from public PC datasets. A risk model was developed, and Gene Set Enrichment Analysis (GSEA) was employed to explore functional differences between low-risk and high-risk groups. The impact of MRRGS was further assessed through mutation and copy number variation (CNV) analysis. The correlation between modeling genes and immune infiltration scores was examined using the ESTIMATE, xCell, and ssGSEA algorithms. Finally, potential therapeutic drugs were tested in various PC patient populations. Results Five CRRGs, including S100A10, CD47, UBXN1, ERBB3, and ST3GAL1, were identified and validated for the development of the risk model. GSEA analysis revealed that high-risk PC patients were associated with ribosome-related pathways and MHC class II pathways. Mutation and CNV analyses indicated that high-risk patients exhibited SMAD4 mutations and a higher frequency of CNVs, while low-risk patients displayed significant alterations in genes such as GSTM1, CFHR3, and RNF43. Furthermore, results from the ESTIMATE, xCell, and ssGSEA analyses demonstrated a notable negative correlation between the ERBB3 and S100A10 genes and immune infiltration-related genes. Based on drug screening outcomes, Sepatronium bromide is recommended for drug trials in high-risk populations, while SB505124 is suggested for low-risk populations. Conclusions The MRRGS constructed from S100A10, CD47, UBXN1, ERBB3, and ST3GAL1 may serve as predictors of prognosis and drug sensitivity for PC patients.